Berry Genomics Co.,Ltd (SHE:000710)

Market Cap	2.94B -33.5%
Revenue (ttm)	922.27M -9.3%
Net Income	-210.11M
EPS	-0.59
Shares Out	353.52M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,604,200
Open	8.18
Previous Close	8.32
Day's Range	8.03 - 8.41
52-Week Range	8.03 - 17.37
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well a...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2010
• Employees: 1,331
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000710

Financial Performance

In 2025, Berry Genomics Co.,Ltd's revenue was 929.82 million, a decrease of -13.76% compared to the previous year's 1.08 billion. Losses were -196.84 million, 2.29% more than in 2024.